These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4818163)

  • 1. Reversible encephalopathy possibly associated with bismuth subgallate ingestion.
    Burns R; Thomas DW; Barron VJ
    Br Med J; 1974 Feb; 1(5901):220-3. PubMed ID: 4818163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Encephalopathy during oral treatment with bismuth salts].
    Michaud PA; Regli F
    Schweiz Med Wochenschr; 1976 Apr; 106(16):550-5. PubMed ID: 988634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxic encephalopathy due to ingestion of bismuth salts: clinical and EEG studies of 45 patients.
    Supino-Viterbo V; Sicard C; Risvegliato M; Rancurel G; Buge A
    J Neurol Neurosurg Psychiatry; 1977 Aug; 40(8):748-52. PubMed ID: 336849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reversible encephalopathies caused by bismuth salts. 5 further cases].
    Lhermitte F; Degos CF; Signoret JL
    Nouv Presse Med; 1975 Feb; 4(6):419-20. PubMed ID: 1129094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bismuth subsalicylate toxicity as a cause of prolonged encephalopathy with myoclonus.
    Gordon MF; Abrams RI; Rubin DB; Barr WB; Correa DD
    Mov Disord; 1995 Mar; 10(2):220-2. PubMed ID: 7753066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Myoclonic encephalopathies induced by bismuth salts. 6 cases observed during long-term oral treatment].
    Buge A; Rancurel G; Poisson M; Dechy H
    Nouv Presse Med; 1974 Oct; 3(36):2315-20. PubMed ID: 4218313
    [No Abstract]   [Full Text] [Related]  

  • 7. [Iatrogenic myoclonic encephalopathies caused by bismuth salts].
    Loiseau P; Henry P; Jallon P; Legroux M
    J Neurol Sci; 1976 Feb; 27(2):133-43. PubMed ID: 1249582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Myoclonic encephalopathy caused by bismuth salts. Efficacy of treatment with dimercaprol].
    Molina JA; Calandre L; Bermejo F; Posadas F; Fernández-Ortega JD
    Med Clin (Barc); 1989 Jun; 93(1):20-2. PubMed ID: 2770373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bismuth Subgallate Toxicity in the Age of Online Supplement Use.
    Sampognaro P; Vo KT; Richie M; Blanc PD; Keenan K
    Neurologist; 2017 Nov; 22(6):237-240. PubMed ID: 29095326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Letter: Reversible acute myoclonic encephalopathies after bismuth salt ingestion].
    Fressinaud L; Emile J; Charbonnel A; Féve JR
    Nouv Presse Med; 1975 Mar; 4(12):885. PubMed ID: 1136684
    [No Abstract]   [Full Text] [Related]  

  • 11. [Myoclonic encephalopathy due to ingestion of insoluble salts of bismuth].
    Cambier J; Dairou R
    Arch Fr Mal App Dig; 1975; 64(1):5-9. PubMed ID: 1164144
    [No Abstract]   [Full Text] [Related]  

  • 12. [Myoclonic bismuth-induced encephalopathy. Case report (author's transl)].
    Loseke N; Retif J; Coune A; Soebert A; Molle L; D'haens J
    Acta Gastroenterol Belg; 1978; 41(1-2):72-80. PubMed ID: 665114
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bismuth myoclonic encephalopathies. Their course and lasting or definitive late complications].
    Buge A; Rancurel G; Dechy H
    Rev Neurol (Paris); 1977; 133(6-7):401-15. PubMed ID: 929035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bismuth myoclonic encephalopathy. Report of two cases (author's transl)].
    Cervelló MA; Alfaro A; Antolín MA; Peñarrocha M
    Med Clin (Barc); 1982 Jul 1-31; 79(3):137-40. PubMed ID: 7109770
    [No Abstract]   [Full Text] [Related]  

  • 15. [Myoclonic encephalopathy caused by bismuth].
    Nogué Xarau S; Sanz Gallén P
    Rev Clin Esp; 1990 Feb; 186(3):145. PubMed ID: 2356356
    [No Abstract]   [Full Text] [Related]  

  • 16. [Letter: Myoclonic encephalopathy and bismuth salt poisoning].
    Cambier J; Mason M; Dairou R
    Nouv Presse Med; 1974 Dec; 3(44):2662. PubMed ID: 4459861
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bismuth encephalopathy in pregnant women. Apropos of a case].
    Quéreux C; Morice J; Level G; Ezes H; Wahl P
    J Gynecol Obstet Biol Reprod (Paris); 1976; 5(1):97-103. PubMed ID: 956618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and electroencephalographic correlates in bismuth-induced myoclonic encephalopathy].
    Gastaut JL; Jouglard J
    Therapie; 1980; 35(3):293-6. PubMed ID: 7423414
    [No Abstract]   [Full Text] [Related]  

  • 19. Pepto bismuth associated neurotoxicity: A rare side effect of a commonly used medication.
    Masannat Y; Nazer E
    W V Med J; 2013; 109(3):32-4. PubMed ID: 23798279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse effects of bismuth subgallate. A further report from the Australian Drug Evaluation Committee.
    Lowe DJ
    Med J Aust; 1974 Nov; 2(18):664-6. PubMed ID: 4453225
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.